What Researchers Did
Researchers reviewed the existing literature on the use of hyperbaric oxygen therapy in urology.
What They Found
They found that hyperbaric oxygen therapy (HBOT) serves as a treatment alternative for urological patients with ischemic conditions unresponsive to conventional therapies. HBOT is particularly useful for intractable hemorrhagic cystitis caused by pelvic radiation, though patient selection requires considering factors like cancer, active viral disease, pneumothorax, and concurrent doxorubicin or cisplatin treatment.
What This Means for Canadian Patients
Canadian patients with specific urological conditions, such as intractable hemorrhagic cystitis or ischemic injuries unresponsive to standard care, may consider hyperbaric oxygen therapy as a complementary treatment option. This therapy could offer an alternative when conventional medical and surgical approaches have been exhausted, but careful patient selection by a specialist is crucial.
Canadian Relevance
This review article has no direct Canadian connection as it does not involve Canadian researchers, institutions, or patient populations.
Study Limitations
A limitation of this review is the call for further investigation into the efficacy of hyperbaric oxygen for conditions like necrotizing fasciitis, posttraumatic ischemic injury, and impaired wound healing, suggesting existing evidence may be incomplete.